NO20070522L - Oral vedvarende frigivelsesformulering av tedisamil med gastriske bibeholdelsesegenskaper - Google Patents
Oral vedvarende frigivelsesformulering av tedisamil med gastriske bibeholdelsesegenskaperInfo
- Publication number
- NO20070522L NO20070522L NO20070522A NO20070522A NO20070522L NO 20070522 L NO20070522 L NO 20070522L NO 20070522 A NO20070522 A NO 20070522A NO 20070522 A NO20070522 A NO 20070522A NO 20070522 L NO20070522 L NO 20070522L
- Authority
- NO
- Norway
- Prior art keywords
- tedisamil
- sustained release
- release formulation
- retention properties
- gastric retention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Den foreliggende oppfinnelsen vedrører en ny vedvarende fiigivelsesformulering med gastriske bibeholdelsesegenskaper som omfatter tedisamil eller et farmasøytisk akseptabelt salt derav og anvendelsen av denne formuleringen ved forebyggelse og behandling av forkammerflimmer og hjerteiskemi.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58279804P | 2004-06-28 | 2004-06-28 | |
EP04102987 | 2004-06-28 | ||
PCT/EP2005/052984 WO2006000583A2 (en) | 2004-06-28 | 2005-06-27 | Oral sustained release formulation of tedisamil with gastric retention properties |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20070522L true NO20070522L (no) | 2007-01-26 |
Family
ID=35782155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20070522A NO20070522L (no) | 2004-06-28 | 2007-01-26 | Oral vedvarende frigivelsesformulering av tedisamil med gastriske bibeholdelsesegenskaper |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1763338B1 (no) |
JP (1) | JP2008504250A (no) |
KR (1) | KR20070028598A (no) |
AT (1) | ATE493974T1 (no) |
AU (1) | AU2005256653B2 (no) |
CA (1) | CA2569919A1 (no) |
DE (1) | DE602005025767D1 (no) |
IL (1) | IL179859A0 (no) |
MX (1) | MXPA06015095A (no) |
NO (1) | NO20070522L (no) |
RU (1) | RU2385724C2 (no) |
WO (1) | WO2006000583A2 (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
KR101050015B1 (ko) * | 2007-09-21 | 2011-07-19 | 동아제약주식회사 | 위체류약물전달시스템을 이용한 애엽 추출물의 약학조성물및 이를 이용한 서방성 경구용 제제 |
WO2009064458A2 (en) | 2007-11-13 | 2009-05-22 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
WO2009157711A2 (ko) * | 2008-06-24 | 2009-12-30 | Park Eun-Seok | 위장체류형 다공성 정제 및 그의 제조 방법 |
US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
AU2010286354A1 (en) * | 2009-08-31 | 2012-04-19 | Depomed, Inc. | Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen |
EP2468264A1 (en) * | 2010-12-27 | 2012-06-27 | Laboratorios Liconsa, S.A. | Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it |
CN103393620B (zh) * | 2013-08-05 | 2016-02-03 | 青岛市中心医院 | 一种阿折地平胶囊剂及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ524641A (en) * | 2000-09-29 | 2004-09-24 | Solvay Pharmaceuticals B | A pharmaceutical hydrophilic gel forming matrix formulation having prolonged release which is ion strength independent |
-
2005
- 2005-06-27 MX MXPA06015095A patent/MXPA06015095A/es unknown
- 2005-06-27 CA CA002569919A patent/CA2569919A1/en not_active Abandoned
- 2005-06-27 KR KR1020077002141A patent/KR20070028598A/ko not_active Application Discontinuation
- 2005-06-27 EP EP05785782A patent/EP1763338B1/en active Active
- 2005-06-27 DE DE602005025767T patent/DE602005025767D1/de active Active
- 2005-06-27 RU RU2007103195/15A patent/RU2385724C2/ru not_active IP Right Cessation
- 2005-06-27 AU AU2005256653A patent/AU2005256653B2/en not_active Ceased
- 2005-06-27 WO PCT/EP2005/052984 patent/WO2006000583A2/en active Application Filing
- 2005-06-27 JP JP2007517305A patent/JP2008504250A/ja not_active Withdrawn
- 2005-06-27 AT AT05785782T patent/ATE493974T1/de not_active IP Right Cessation
-
2006
- 2006-12-05 IL IL179859A patent/IL179859A0/en unknown
-
2007
- 2007-01-26 NO NO20070522A patent/NO20070522L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1763338A2 (en) | 2007-03-21 |
ATE493974T1 (de) | 2011-01-15 |
JP2008504250A (ja) | 2008-02-14 |
AU2005256653B2 (en) | 2010-10-14 |
IL179859A0 (en) | 2007-05-15 |
CA2569919A1 (en) | 2006-01-05 |
DE602005025767D1 (de) | 2011-02-17 |
AU2005256653A1 (en) | 2006-01-05 |
WO2006000583A3 (en) | 2006-10-12 |
MXPA06015095A (es) | 2007-07-17 |
RU2007103195A (ru) | 2008-08-10 |
KR20070028598A (ko) | 2007-03-12 |
WO2006000583A2 (en) | 2006-01-05 |
EP1763338B1 (en) | 2011-01-05 |
RU2385724C2 (ru) | 2010-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20070522L (no) | Oral vedvarende frigivelsesformulering av tedisamil med gastriske bibeholdelsesegenskaper | |
UA94390C2 (ru) | Применение производных индолинонов, предназначенных для лечения или предупреждения идиопатического фиброза легких | |
CY1119007T1 (el) | Συνθεσεις και μεθοδοι αγωγης πνευμονικης υπερτασης | |
DE60332629D1 (de) | Phenyl-(4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yi)aminderivate | |
WO2004030611A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
WO2009017837A3 (en) | Sublingual fentanyl spray | |
NO20064792L (no) | Anvendelse av rotigotin til behandling og forbinding av Parkinsons pluss syndrom. | |
NO20080088L (no) | Sterkt biotilgjengelige orale forsinkede frigjoringsformer av O-desmetylvenlafaksin | |
WO2007038112A3 (en) | Combination of rosiglitazone and donepezil for improvement of cognitive function | |
TW200637544A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
EA200702282A1 (ru) | Комбинация феррохина и производного артемизинина для лечения малярии | |
EP2384746A3 (en) | Dual release oral tablet compositions of dexlansoprazole | |
TW200635595A (en) | Medicaments for the treatment of prevention of fibrotic diseases | |
NO20091644L (no) | Hurtig desintegrerende, lyofiliserte orale formuleringer av en trombinreseptorantagonist | |
WO2014119985A3 (es) | Composición farmacéutica con un inhibidor selectivo de la enzima fosfodiesterasa en forma de gel oral | |
TW200603793A (en) | Oral sustained release formulation of tedisamil with gastric retention properties | |
TW200640446A (en) | Prophylactic anti-stress agent | |
DE602005023742D1 (de) | Formulierung von 3-amino-8-(1-piperazinyl)-2h-1benzopyran-2-on mit verzögerter freisetzung | |
EA200801890A1 (ru) | Средство для лечения шума в ушах | |
WO2005107871A3 (en) | Pyrroloquinoline quinone drugs for treatment of cardiac injury | |
FI3448430T3 (fi) | Asetyylikoleeniesteraasi-inhibiittorin ja idalopirdiinin käyttö Parkinsonin taudin potilaiden kaatumisten vähentämiseksi | |
TR201901012T4 (tr) | Arteriosklerozun tedavisinde nor-safra asitlerinin kullanımı. | |
ATE525064T1 (de) | Pharmazeutische zusammensetzung mit desloratadin | |
TR201001862A1 (tr) | Kontrollü salım gerçekleştiren pramipeksol formülasyonları. | |
CY1114028T1 (el) | Φαρμακευτικες συνθεσεις για τη θεραπεια των ακροχορδωνων |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |